Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes

OBJECTIVE: Diabetes is the leading cause of nontraumatic lower-extremity amputations (LEAs). Identification of patients with foot ulcers at risk for amputation remains clinically challenging. Plasma copeptin, a surrogate marker of vasopressin, is associated with the risk of cardiovascular and renal...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Care
Auteurs principaux: Potier, Louis, Roussel, Ronan, Marre, Michel, Bjornstad, Petter, Cherney, David Z., El Boustany, Ray, Fumeron, Frédéric, Venteclef, Nicolas, Gautier, Jean-François, Hadjadj, Samy, Mohammedi, Kamel, Velho, Gilberto
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2019
Sujets:
Pathophysiology/Complications
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973542/
https://ncbi.nlm.nih.gov/pubmed/31582427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1062
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires